SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: 5,17,37,5,101,... who wrote (111)5/31/1998 5:52:00 PM
From: Lee G. Sommer  Respond to of 2515
 
Thanks for the Dow Jones story. I believe I'll hold off on this one.



To: 5,17,37,5,101,... who wrote (111)6/10/1998 11:21:00 PM
From: 5,17,37,5,101,...  Read Replies (1) | Respond to of 2515
 
Recently sold half of my position at $11.5. IMO IMCL is in a trading range bound by $9 and $14. I would be a heavy buyer below $9.50 and a seller around $12 to $13. The news is out on this company. The anticancer drugs are in the limelight. But IMCL must show real progress before stock proceeds to $20 area.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News